title: [Nigedase in the combined treatment of patients with chronic pancreatitis and enterocolitis].
abstract: The authors examined the efficacy of a new native agent of lipolytic action (nigedase, made in the USSR) used for the treatment of digestive disorders in 62 patients with chronic diseases of the pancreas and enterocolitis. Nigedase should be taken 1-2 tablets daily for 3-4 weeks. By its lipolytic action nigedase is more active than festal.
authors.forename: L V
authors.initials: LV
authors.lastname: Dudar'
authors.forename: A N
authors.initials: AN
authors.lastname: Erokhina
authors.forename: I L
authors.initials: IL
authors.lastname: Kliaritskaia
mesh_terms: D002908:Chronic Disease; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D004760:Enterocolitis / Q000188:drug therapy*; D006801:Humans; D010184:Pancreatic Extracts / Q000627:therapeutic use; D010195:Pancreatitis / Q000188:drug therapy*; D010936:Plant Extracts / Q000627:therapeutic use*; D013607:Tablets; D013997:Time Factors
chemical_list: D010184:Pancreatic Extracts; D010936:Plant Extracts; D013607:Tablets; C061936:festal; C061937:nigedase
vernacular_title: Nigedaza v kompleksnom lechenii bol'nykh khronicheskim pankreatitom i énterokolitom.